The Food and Drug Administration on Tuesday approved a new generic version of valsartan to alleviate recent shortages of the blood pressure medication following a series of safety recalls. There ...

The U.S. Food and Drug Administration has approved a new generic of the blood pressure medication valsartan to help alleviate a recent shortage due to multiple safety recalls.. Since last summer ...

A food recall of nearly 6,000 cases of cookies distributed across 15 states has been given the U.S. Food and Drug ...

At present, the HeartMate 3, which was first approved by the FDA in 2017, is the only medical option for many patients with end-stage heart failure and who do not qualify for a transplant.

Johnson & Johnson’s Abiomed has recalled automated controllers for its Impella heart pumps over a fault linked to three ...

Although Tissium first demonstrated its polymer material as a cardiovascular sealant, the application that the FDA just ...

Recent recalls, FDA warnings about eye care products are concerning, ... 4 min read. Experts say artificial tears are not required to have FDA approval before going on the market, ...

Recall: FDA recalls more than 233,000 bottles of antidepressant over possible cancerous chemical What is duloxetine and how does it work? ... new study shows FDA approves new twice-yearly HIV shot.

The Food and Drug Administration (FDA) has recalled more than 500,000 COVID-19 tests over concerns of them being contaminated with bacteria. The FDA said in a release Thursday that consumers and ...

The HeartMate 3 has supplanted the HeartMate II, which received FDA approval in 2008. If the new recall leads to the device being removed from the market, end-stage heart failure patients could ...

The HeartMate 3 has supplanted the HeartMate II, which received FDA approval in 2008. If the new recall leads to the device being removed from the market, end-stage heart failure patients could ...

The HeartMate 3 has supplanted the HeartMate II, which received FDA approval in 2008. If the new recall leads to the device being removed from the market, end-stage heart failure patients could ...